ANDA 77395, held by Apotex. Paroxetine Hydrochloride.
As of Nov 21, 2026, ANDA 77395 (Paroxetine Hydrochloride), held by Apotex, was first approved by FDA on Dec 4, 2006, with 14 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 4, 2006 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Paroxetine HydrochlorideEQ 10MG BASE/5ML · suspension;oral | Paroxetine Hydrochloride | Discontinued |
| Mar 13, 2025 | Supplement 16Labeling · Standard review | Approved | None posted |
| Jul 8, 2024 | Supplement 15Labeling · Standard review | Approved | None posted |
| Mar 31, 2022 | Supplement 14Labeling · Standard review | Approved | None posted |
| Mar 31, 2022 | Supplement 13Labeling · Standard review | Approved | None posted |
| Mar 17, 2020 | Supplement 12Labeling · Standard review | Approved | None posted |
| Jan 19, 2015 | Supplement 11Labeling · Standard review | Approved | None posted |
| Jan 19, 2015 | Supplement 10Labeling · Standard review | Approved | None posted |
| Jan 31, 2013 | Supplement 9Labeling | Approved | None posted |
| Mar 5, 2010 | Supplement 8Labeling | Approved | None posted |
| May 7, 2009 | Supplement 7Labeling | Approved | None posted |
| May 7, 2009 | Supplement 6Labeling | Approved | None posted |
| Dec 15, 2008 | Supplement 5Labeling | Approved | None posted |
| Jul 9, 2007 | Supplement 2Labeling | Approved | None posted |
| Jul 9, 2007 | Supplement 1Labeling | Approved | None posted |
| Dec 4, 2006 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters